Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.94 USD | +5.22% | +14.63% | +63.99% |
23/04 | Edgewise Therapeutics Secures Orphan Drug Designations for Sevasemten in EU | MT |
22/04 | RBC Raises Price Target on Edgewise Therapeutics to $32 From $28, Keeps Outperform, Speculative Risk | MT |